Toxic epidermal necrolysis in a mother and fetus

Journal of the American Academy of Dermatology

Volumn 55, Issue 5 SUPPL., 2006, Pages

  Rodriguez, Georgette ^a   Trent, Jennifer T ^a   Mirzabeigi, Marjan ^b   Zaulyanov, Larissa ^a   Bruce, Jocelyn ^b   Vincek, Vladimir ^b  

^a Departments of Dermatology and Cutaneous Surgery   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PHENYTOIN; VALPROATE SEMISODIUM;

ADULT; ARTICLE; CASE REPORT; CAUSE OF DEATH; CLINICAL EXAMINATION; CONJUNCTIVITIS; DISEASE TRANSMISSION; DRUG SUBSTITUTION; FEMALE; FETUS DISEASE; FEVER; HUMAN; HUMAN TISSUE; MATERNAL DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PUNCH BIOPSY; RASH; SEIZURE; SEPTICEMIA; SKIN BIOPSY; SKIN EDEMA; STILLBIRTH; TOXIC EPIDERMAL NECROLYSIS;

ADOLESCENT; ANTICONVULSANTS; BIOPSY; DISEASE TRANSMISSION, VERTICAL; EPIDERMAL NECROLYSIS, TOXIC; EPILEPSY; FEMALE; FETAL DEATH; FETUS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PHENYTOIN; PREGNANCY; STILLBIRTH;

EID: 33749684864     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.09.021     Document Type: Article

References (14)

1. Roujeau J.C., Kelly J.P., and Naldi L. Medication use and the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis. N Engl J Med 333 (1995) 1600-1609
2. Lipper G.M., Arndt K.A., and Dover J.S. Recent therapeutic advances in dermatology. JAMA 283 (2000) 175-177
3. Lohmeier K., Megahed M., Schulte K.W., Stannigel H., Mayatepek E., and Schroten H. Toxic epidermal necrolysis in a premature infant of 27 weeks gestational age. Br J Dermatol 152 (2005) 150-151
4. De Groot R., Oranje A.P., Vuzevski V.D., and Mettau J.W. Toxic epidermal necrolysis probably due to Klebsiella pneumoniae sepsis. Dermatologica 169 (1984) 88-90
5. Hawk R.J., Storer J.S., and Daum R.S. Toxic epidermal necrolysis in a 6-week-old infant. Pediatr Dermatol 2 (1985) 197-200
6. Scully M.C., and Frieden I.J. Toxic epidermal necrolysis in early infancy. J Am Acad Dermatol 27 (1992) 340-344
7. Pacheco H., Araujo T., and Kerdel F. Toxic epidermal necrolysis in a pregnant, HIV-infected woman. Int J Dermatol 41 (2002) 600-601
8. Claessens N., Delbeke L., Lambert J., Matthieu L., Lafaire C., and Van Marck E. Toxic epidermal necrolysis associated with treatment for preterm labor. Dermatology 196 (1998) 461-462
9. Wolkenstein P., Charue D., Laurent P., Revuz J., Roujeau J.C., and Bagot M. Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 131 (1995) 544-551
10. Roujeau J.C., Bracq C., Huyn N.T., Chaussalet E., Raffin C., and Duedari N. HLA phenotypes and bullous cutaneous reactions to drugs. Tissue Antigens 28 (1986) 251-254
11. Fischer P.R., and Shigeoka A.O. Familial occurrence of Stevens Johnson syndrome. Am J Dis Child 137 (1983) 914-916
12. Posadas S.J., Padial A., Torres M.J., Myorga C., Leyva L., Sanchez E., et al. Delayed reactions to drugs show levels of perforin, granzyme, and FasL to be related to disease severity. J Allergy Clin Immunol 109 (2002) 155-161
13. Paul C., Wolkenstein P., Adle H., Wechsler J., Garchon H.J., Revuz J., et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 134 (1996) 710-714
14. Nassif A., Bensussan A., Boumsell L., Deniaud A., Moslehi H., Wolkenstein P., et al. Toxic epidermal necrolysis: effector cells are drug specific cytotoxic T cells. J Allergy Clin Immunol 114 (2004) 1209-1215